SEATTLE, WA / ACCESSWIRE / September 2, 2020 / Riverdale Oil & Gas Corporation (OTC PINK:RVDO)(the "Company"), announced today that Hempstract, LLC has executed a Joint Processing Agreement with IsoPhlora, Inc.
In a joint agreement with IsoPhlora, Inc., Hempstract, LLC and their client, Epitome, Inc., Hempstract will complete the extraction process of a large quantity of industrial hemp provided by Epitome. Hempstract will retain 40% of the resulting crude oil and the remaining amount will be provided to IsoPhlora for further processing to the client.
Justin Costello, President of Hempstract commented on the Agreement: "This tolling agreement represents a great opportunity for us to expand production at the Hempstract facilities to process a considerable magnitude of industrial hemp for our client."
About Riverdale Oil & Gas Corporation
Riverdale Oil & Gas Corporation (OTC PINK:RVDO) is a Nevada registered publicly-traded company.
About Hempstract, LLC
Located in Warden, Washington, Hempstract offers business partners premium CBD Solutions they can trust at competitive prices. Hempstract and its laboratories go to great lengths to ensure that all of its solutions are of the highest quality and control standards and provides pure, high-quality, and safe, CBD isolate and oil to its customers.
About IsoPhlora, Inc.
IsoPhlora, Inc. is a bioscience company in Portland, Oregon specializing in research, development, and processing of botanical solutions. The company was founded to provide a scalable, innovative pathway from the farmer to the consumer.
For more information, please contact:
Richard Hawkins
IR@rvdoil.com
Forward-looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
SOURCE: Riverdale Oil & Gas Corporation
View source version on accesswire.com:
https://www.accesswire.com/604596/Hempstract-Executes-Processing-Agreement-with-IsoPhlora
